Pharmaceuticals Industry Market Index
The Pharmaceuticals Industry in the Health Care Sector includes companies engaged in the research, development, or production of pharmaceuticals (including veterinary drugs).
The Pharmaceuticals industry index is a market composite index that includes 13 stocks from public trading companies and ADRs with the largest market capitalizations in the Pharmaceuticals industry.
The list of stocks in the Pharmaceuticals industry includes Novo Nordisk A/S, Novartis AG, Viatris Inc., Sanofi, Glaxosmithkline PLC, Embecta Corp, Astrazeneca PLC, Merck & Co Inc, Johnson & Johnson, Zoetis Inc, Eli Lilly and Co, Pfizer Inc and Bristol-Myers Squibb Co.
4/11/2025 Health Care Sector Pharmaceuticals Industry
$21,142
Change: +2.48%
Open: $21,055
High: $21,236
Low: $20,563
| Novo Nordisk A/S (NVO) |
+5.75%
|
| Novartis AG (NVS) |
+3.98%
|
| Viatris Inc. (VTRS) |
+3.86%
|
| Sanofi (SNY) |
+3.71%
|
| Glaxosmithkline PLC (GSK) |
+3.10%
|
| Pharmaceuticals Industry |
+2.48%
|
| Embecta Corp (EMBC) |
+2.41%
|
| Astrazeneca PLC (AZN) |
+2.19%
|
| Merck & Co Inc (MRK) |
+2.10%
|
| Johnson & Johnson (JNJ) |
+2.04%
|
| Zoetis Inc (ZTS) |
+1.66%
|
| Eli Lilly and Co (LLY) |
+1.60%
|
| Pfizer Inc (PFE) |
+1.48%
|
| Bristol-Myers Squibb Co (BMY) |
+0.50%
|
Index Value: $21,142 +2.48%
Volume: 3.72B Average Volume (3 month): 3.92B
Market Capitalization: $53.32T
EBITDA: $6.76T
PEG Ratio (5 year Expected): 18.39
Dividend Yield: 3.19%
Dividend Rate: $643.88
Dividend Yield (Forward): 2.36%
Dividend Rate (Forward): $475.41
Shares Outstanding: 707.55B
Book Value: $4,733
Short Ratio: 1.37
Price Target (1 year): $21,512
Volume: 3.72B Average Volume (3 month): 3.92B
Market Capitalization: $53.32T
EBITDA: $6.76T
PEG Ratio (5 year Expected): 18.39
Dividend Yield: 3.19%
Dividend Rate: $643.88
Dividend Yield (Forward): 2.36%
Dividend Rate (Forward): $475.41
Shares Outstanding: 707.55B
Book Value: $4,733
Short Ratio: 1.37
Price Target (1 year): $21,512
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| NVO | Novo Nordisk A/S | 64.73 | +5.75% | 10.70M | 1.23 | 10.47% |
| NVS | Novartis AG | 107.52 | +3.98% | 4.75M | 1.96 | 7.98% |
| VTRS | Viatris Inc. | 7.54 | +3.86% | 16.25M | 1.15 | 0.34% |
| SNY | Sanofi | 51.50 | +3.71% | 2.50M | 0.92 | 4.73% |
| GSK | Glaxosmithkline PLC | 34.64 | +3.10% | 9.08M | 1.66 | 2.64% |
| Pharmaceuticals Industry | 21,142.34 | +2.48% | 3.72B | 0.95 | 42.18% | |
| EMBC | Embecta Corp | 12.30 | +2.41% | 559,872 | 0.98 | 0.03% |
| AZN | Astrazeneca PLC | 66.29 | +2.19% | 5.76M | 0.93 | 15.44% |
| MRK | Merck & Co Inc | 79.18 | +2.10% | 13.40M | 0.78 | 7.51% |
| JNJ | Johnson & Johnson | 151.73 | +2.04% | 6.90M | 0.68 | 13.73% |
| ZTS | Zoetis Inc | 149.44 | +1.66% | 2.82M | 0.90 | 2.51% |
| LLY | Eli Lilly and Co | 732.41 | +1.60% | 3.60M | 0.95 | 26.08% |
| PFE | Pfizer Inc | 21.91 | +1.48% | 45.20M | 0.92 | 4.67% |
| BMY | Bristol-Myers Squibb Co | 50.71 | +0.50% | 10.75M | 0.87 | 3.88% |
| Symbol | Security | Market Cap | Div Yield | PEG Ratio |
| NVO | Novo Nordisk A/S | 458.578B | 9.92% | |
| NVS | Novartis AG | 206.465B | 3.80% | |
| VTRS | Viatris Inc. | 15.576B | 3.69% | |
| SNY | Sanofi | 120.344B | ||
| GSK | Glaxosmithkline PLC | 68.267B | 1.81% | |
| Pharmaceuticals Industry | $53.32T | 3.19% | 18.39 | |
| EMBC | Embecta Corp | 788.608M | 4.16% | |
| AZN | Astrazeneca PLC | 197.819B | 4.69% | |
| MRK | Merck & Co Inc | 244.211B | 3.15% | |
| JNJ | Johnson & Johnson | 368.366B | 3.14% | |
| ZTS | Zoetis Inc | 79.207B | 0.95% | |
| LLY | Eli Lilly and Co | 710.844B | 0.69% | |
| PFE | Pfizer Inc | 142.241B | 6.72% | |
| BMY | Bristol-Myers Squibb Co | 118.101B | 4.23% | |
Back to Market Summary